Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

Neoplasia

Volumn 3, Issue 1, 2001, Pages 53-61

  Gallo, Oreste ^a   Franchi, Alessandro ^a   Magnelli, Lucia ^a   Sardi, Iacopo ^a   Vannacci, Alfredo ^a   Boddi, Vieri ^a   Chiarugi, Vincenzo ^a   Masini, Emanuela ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiogenesis; COX 2; Head and neck cancer; VEGF

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; INDOMETACIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; ENZYME INHIBITION; GROWTH INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION;

AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; INDOMETHACIN; ISOENZYMES; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFONAMIDES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035097541     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900127     Document Type: Article

References (54)

1. Prostaglandins in squamous cell carcinoma of the larynx: Tumor and peritumor synthesis
2. Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx
3. Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients
4. Arachidonic acid metabolism: A primer for head and neck surgeons
5. Eicosanoids and the immunology of cancer
6. Effects of indomethacin on the growth of cultured mammary tumors
7. Prostaglandins and host defense in cancer
8. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
9. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
10. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
11. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
12. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester
13. Benzo [a] pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
14. Colorectal cancer and nonsteroidal anti-inflammatory drugs
15. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
16. Indomethacin in breast cancer
17. Skin cancers in xeroderma pigmentosum: Response to indomethacin and steroids
18. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
19. Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition
20. Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs
21. Regression of head and neck carcinoma with a prostaglandin - Synthesis inhibitor
22. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
23. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostagladin endoperoxide synthase 2
24. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
25. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
26. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites
27. Cyclooxygenase-2 expression in human esophageal carcinoma
28. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma
29. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
30. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumor stage and vascularization in renal cell carcinoma
31. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
32. Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer
33. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites
34. Angiogenesis and tumor progression are under the control of nitric oxide in head and neck cancer
35. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts
36. Angiogenesis
37. Vascular endothelial growth factor is a secreted angiogenic mitogen
38. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
39. Vascular endothelial growth factor in squamous cell head and neck carcinoma: Expression and prognostic significance
40. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
41. Induction of vascular endothelial growth factor expression of prostaglandin E2 and E1 in osteoblasts
42. PGE2 and angiogenesis
43. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
44. Host cyclooxygenase -2 modulates carcinoma growth
45. Expression of cyclooxygenase -1 and -2 in human colorectal cancer
46. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
47. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
48. Regulation of prostaglandin production by nitric oxide; an in vivo analysis
49. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages
50. Regulation of the inducible cyclo-oxygenase pathway in human cultered airway epithelial (A549) cells by nitric oxide
51. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
52. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
53. Loss of the p53 mutation after irradiation is associated with increased aggressiveness in recurred head and neck cancer
54. iNOS and p53 as play-makers of tumor angiogenesis